GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Rossari Biotech Ltd

Rossari Biotech: Ms. Esha Padmanabhan Achan Re-appointed Independent Director

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 27 May 2026, 09:09 PM IST  ·  BSE ID: 44cb924f-e480-4995-b6f7-4a035f5b56b0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has decided to keep Ms. Esha Padmanabhan Achan as an independent director for another three years.
🤖 AI Summary
  • Ms. Esha Padmanabhan Achan re-appointed Non-Executive Independent Director for a second term.
  • Re-appointment is for three consecutive years, from October 21, 2026 to October 20, 2029.
  • Board recommendation follows review by the Nomination and Remuneration Committee.
  • Re-appointment is subject to the approval of the Company's Members.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Director's DIN
10350369
Term Duration
3 years
Term Start Date
October 21, 2026
Term End Date
October 20, 2029
🏢 How This Affects the Company
⚙️
Operational Impact
This re-appointment ensures continuity on the Board of Directors, maintaining existing governance structures.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to vote on the re-appointment of Ms. Esha Padmanabhan Achan at the ensuing general meeting.
👤
Who Is Affected
All shareholders of Rossari Biotech Ltd. will be affected as their voting rights are exercised for board composition.
🔍
Management Signal
This signals management's intent to retain experienced directors and maintain board stability and independence.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Outcome of shareholder vote on re-appointment
Subsequent board meeting minutes for director changes
Annual Report detailing board composition for FY27
LOW RISK Routine management decision regarding director re-appointment with no immediate financial or operational risks.
💡 Investor Takeaway
Rossari Biotech's Board has recommended re-appointing Ms. Esha Padmanabhan Achan as Non-Executive Independent Director for a second three-year term, commencing October 21, 2026.
❓ Frequently Asked Questions
Who has been re-appointed as a director at Rossari Biotech?
Ms. Esha Padmanabhan Achan has been re-appointed as a Non-Executive Independent Director.
What is the duration of Ms. Esha Padmanabhan Achan's new term?
Ms. Esha Padmanabhan Achan's re-appointment is for a second term of 3 years.
When does Ms. Esha Padmanabhan Achan's new director term commence?
Her re-appointment term commences from October 21, 2026, to October 20, 2029.
Is Ms. Esha Padmanabhan Achan's re-appointment final?
No, the re-appointment is subject to the approval of the Members of the Company.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.